Schizophrenia

The Schizophrenia pipeline: 62 tracked drugs, 30 approved for this indication.

30 approved / phase 410 Phase 312 Phase 22 Phase 1/27 Phase 11 preclinical / unstaged

Compare the share prices of listed companies in Schizophrenia →

Total attributable cost

$49.0B

$15,957/patient

Drug spend

Not yet sourced

How this is calculated ↗

All severities · US

The Schizophrenia pipeline

Key trial results for every approved and late-stage drug: Schizophrenia results by drug.

← all assets